131 related articles for article (PubMed ID: 10485237)
41. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
42. Accuracy of ultrasonography and 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study.
Lumachi F; Tregnaghi A; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Cecchin D; Bui F
Eur J Surg Oncol; 2006 Nov; 32(9):933-6. PubMed ID: 16797155
[TBL] [Abstract][Full Text] [Related]
43. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.
Lam WW; Yang WT; Chan YL; Stewart IE; Metreweli C; King W
Eur J Nucl Med; 1996 May; 23(5):498-503. PubMed ID: 8698052
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection.
Lumachi F; Ferretti G; Povolato M; Marzola MC; Zucchetta P; Geatti O; Bui F; Brandes AA
Eur J Surg Oncol; 2001 Apr; 27(3):256-9. PubMed ID: 11373101
[TBL] [Abstract][Full Text] [Related]
45. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
[TBL] [Abstract][Full Text] [Related]
46. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
[TBL] [Abstract][Full Text] [Related]
47. [Combined use of 99mTc-MIBI scintigraphy and ultrasonography (US) in the diagnosis of axillary lymphatic metastasis in patients with breast cancer].
Kanaev SV; Novikov SN; Krivorot'ko PV; Semiglazov VF; Kryzhevitskiĭ PI; Zhukova LA; Semënov II; Semiglazova TIu; Negustorov IuF
Vopr Onkol; 2013; 59(1):52-8. PubMed ID: 23805451
[TBL] [Abstract][Full Text] [Related]
48. Single-photon-emission computed tomography (SPECT) with technetium-99m sestamibi in the diagnosis of small breast cancer and axillary lymph node involvement.
DeCesare A; De Vincentis G; Gervasi S; Crescentini G; Fiori E; Bonomi M; Crocetti A; Sterpetti AV
World J Surg; 2011 Dec; 35(12):2668-72. PubMed ID: 22002494
[TBL] [Abstract][Full Text] [Related]
49. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
[TBL] [Abstract][Full Text] [Related]
50. Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide.
Chiti A; Maffioli LS; Agresti R; Spinelli A; Savelli G; Casteliani MR; Giovanazzi R; Greco M; Bombardieri E
Tumori; 1997; 83(2):537-8. PubMed ID: 9226013
[No Abstract] [Full Text] [Related]
51. The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer.
Danielsson R; Reihnér E; Grabowska A; Boné B
Acta Radiol; 2000 Sep; 41(5):441-5. PubMed ID: 11016763
[TBL] [Abstract][Full Text] [Related]
52. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography.
Usmani S; Niaz K; Maseeh-Uz-Zaman ; Niyaz K; Khan HA; Habib S; Kamal S
Nucl Med Commun; 2007 Nov; 28(11):842-6. PubMed ID: 17901766
[TBL] [Abstract][Full Text] [Related]
53. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer.
Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Cannas P; Picardi V; Colella AC
Anticancer Res; 1997; 17(3B):1607-10. PubMed ID: 9179202
[TBL] [Abstract][Full Text] [Related]
54. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
55. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
56. Axillary lymph node staging in breast cancer: clinical value of single photon emission computed tomography-computed tomography (SPECT-CT) with 99mTc-methoxyisobutylisonitrile.
Novikov SN; Krzhivitskii PI; Kanaev SV; Krivorotko PV; Ilin ND; Jukova LA; Ponomareva OI
Ann Nucl Med; 2015 Feb; 29(2):177-83. PubMed ID: 25398309
[TBL] [Abstract][Full Text] [Related]
57. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
[TBL] [Abstract][Full Text] [Related]
58. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
60. Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent "99mTc MIbI".
Aras G; Arican P; Cam R; Küçük NO; Ibiş E; Tüzüner A; Soylu A
Ann Nucl Med; 2002 Apr; 16(2):121-6. PubMed ID: 12043906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
